Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1645089 | 0.84 | F2 (0.37) | F2F10PRSS1GAA | |
| SCHEMBL3814397 | 0.82 | GAA (0.31) | GAA | |
| SCHEMBL2239472 | 0.82 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2F10 | |
| SCHEMBL7812408 | 0.82 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2F10 | |
| SCHEMBL2239478 | 0.82 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2F10 | |
| SCHEMBL2239474 | 0.82 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2F10 | |
| SCHEMBL13617075 | 0.82 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CF2F10 | |
| SCHEMBL12343884 | 0.82 | F2 (0.33) | F2F10PRSS1BACE1GAA | |
| SCHEMBL12349810 | 0.81 | ADRB3 (0.41) | ADRB3ADRA2BADRA2CF2F10 | |
| SCHEMBL14031132 | 0.80 | GAA (0.35) | F2F10PRSS1BACE1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2033654-A1 | Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus | Bristol-Myers Squibb Company (US) | 2009-03-11 | — | — | EP | disclosed |